Goldman Sachs downgraded MAKO Surgical (NASDAQ: MAKO) from Buy to Neutral with a price target of $17 (down from $36) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE